Skin Disorders News

In order to better manage symptoms of atopic dermatitis, health care professionals must consider aggravating factors and systemic immunotherapy, according to a study published in the Chinese Medical Journal.

Abrocitinib may be an effective and well-tolerated treatment for adults with prurigo nodularis and chronic pruritus of unknown origins, according to a study.

Roflumilast cream 0.15% demonstrated long-term efficacy and tolerability in adults and children aged 6 years and older with atopic dermatitis, Arcutis announced in a press release.

Both organic and inorganic pigments used in cosmetic tattoos, also known as permanent makeup, may cause allergic contact dermatitis, according to a study.

CLEVELAND — For patients with atopic dermatitis, today’s systemic therapies can lead to long-standing on-drug relief, but long-term, off-drug remission remains a goal that has yet to be reached, according to Raj Chovatiya, MD, PhD.

CLEVELAND — For patients with chronic spontaneous urticaria, lab testing can help to phenotype disease and guide treatment, according to James Fernandez, MD, PhD, an allergy and immunology specialist at the Cleveland Clinic.

Dermatologist Raj Chovatiya, MD, PhD, MSCI, recently spoke to Healio about his new findings in seborrheic dermatitis and how to best treat diverse patient groups with this condition.

Topical tapinarof cream showed significant improvement of moderate to severe atopic dermatitis while being well tolerated by adults and children down to age 2 years, according to two phase 3 clinical trials.

Due to a small increase in eczematous dermatitis, older adults taking antihypertensive drugs should be monitored and this possibility considered when assessing for eczema, according to a study.

Johnson & Johnson will pay $850 million to acquire the biotechnology company Proteologix Inc., the company announced in a press release.